Physician

Mario R Velasco, MD

According to 2025 Medicare claims, Mario Velasco, MD (NPI: 1326007782) practices hematology/oncology in the Decatur, IL market, with the plurality of this provider's patient population coming from Macon, IL. This provider's primary affiliated billing organization is CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS, S.C. (NPI: 1871580142; TIN: 371160364) and primary practice location at 62526-5858. Velasco is affiliated with the IRCCO (ACO ID: A2619), participating under the MSSP model.

Velasco's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 697 traditional Medicare patients, billed 244,693 HCPCS/CPT codes, and received $4,385,740 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,326 prescription claims across 397 beneficiaries totaling $4,567,542 in drug costs, led by Revlimid (Lenalidomide). DME data shows 36 claims. Open Payments data shows 159 records totaling $3,319. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $2,023,035 and ending at $4,385,740. Concurrently, Part D prescription costs have risen steadily, from $1,534,573 to $4,567,542. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $14,339 to $3,051.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	747	220,714	$2,023,035
2016	766	264,624	$3,098,138
2017	787	204,494	$2,991,426
2018	733	259,266	$4,011,539
2019	769	312,839	$4,231,842
2020	698	295,366	$4,530,442
2021	618	219,961	$3,622,096
2022	591	228,516	$3,021,153
2023	534	202,005	$3,111,551
2024	697	244,693	$4,385,740

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	236	1,963	$1,534,573
2016	274	2,306	$2,128,343
2017	277	2,112	$2,975,298
2018	288	2,298	$2,682,209
2019	276	1,946	$2,349,852
2020	284	1,985	$3,412,745
2021	285	2,079	$3,570,460
2022	305	2,041	$3,489,007
2023	286	1,942	$2,725,747
2024	397	2,326	$4,567,542

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	22	270	$21,335
2016	N/R	224	$37,473
2017	12	200	$41,504
2018	N/R	172	$15,185
2019	N/R	154	$14,667
2020	N/R	90	$6,278
2021	N/R	39	$3,966
2022	N/R	29	$2,155
2023	N/R	43	$1,179
2024	N/R	36	$1,214

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	535	1,150	$89
80053	Blood test, comprehensive group of blood chemicals	453	1,417	$10
36415	Insertion of needle into vein for collection of blood sample	445	1,343	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	340	715	$8
83615	Lactate dehydrogenase (enzyme) level	408	1,020	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	31	868	$560,467
Calquence	Acalabrutinib Maleate	38	1,140	$542,054
Orserdu	Elacestrant Hcl	18	540	$410,470
Xtandi	Enzalutamide	28	840	$356,637
Tagrisso	Osimertinib Mesylate	19	570	$318,182

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	12	$698
E1392	Portable oxygen concentrator, rental	Y	N/R	12	$377
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	12	$138

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	159	$3,319	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mario R. Velasco, MD?

Tedicare shows public-source Medicare data for Mario R. Velasco, MD (NPI 1326007782), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mario R. Velasco, MD have ACO affiliation data?

Mario R. Velasco, MD is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619).

What billing organization is linked to Mario R. Velasco, MD?

Mario R. Velasco, MD is linked to CANCER CARE SPECIALISTS OF CENTRAL ILLINOIS, S.C. (billing NPI 1871580142) in the available physician profile data.

Does Mario R. Velasco, MD have Open Payments data?

Mario R. Velasco, MD has 159 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.